HYBRID EVENT: You Can Participate In Person At Kowloon City, Hong Kong Or Virtually From Your Home Or Work
ICAORC · Registering as Listener

International Conference on Advances in Oncology Research and Care

3–4 Aug 2026 Kowloon City, Hong Kong Standard / Physical Participation
Listener Registration
$199
virtual · $289 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.
All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon code

Have a code? Apply it here — the discount updates the total immediately.
Apply
Try FAST10 for 10% off on eligible registrations.

1. Policy on Cancellations & Refunds :

  • A full refund is possible only if the cancellation request is submitted at least 70 days before the conference, with formal paperwork completed at least 60 days prior.
  • If cancellation occurs between 60 and 30 days before the event, partial refunds may be granted based on administrative costs incurred.
  • Cancellations made within 30 days of the event are non-refundable, though participants will receive a credit valid for one year.
  • Registrations made less than 30 days before the event are not eligible for refunds, but may be transferred to another ISIT conference.
  • Since this conference is hybrid format, the organizer reserves the right to conduct the event either in-person or virtually. Please note that no refunds will be issued due to changes in the event format.
  • Virtual registration fees are non-refundable. A credit will instead be issued for use at a future conference event.

2. Participation & Registration Requirements :

  • To attend an ISIT event, participants must complete the registration process within the stipulated time.
  • The event schedule, venue, and format are subject to changes at the discretion of the organizers, with prior notice sent via email.
  • ISIT is not liable for any financial losses resulting from changes in event details.
  • Fees paid for registration are strictly non-refundable.
  • If the primary author cannot participate, a co-author may attend instead, but refunds will not be granted for non-attendance.

3. Submission & Publication Norms :

  • Researchers submitting papers to ISIT must ensure their institution or supervisor is aware of their submission.
  • Each submission is subject to a rigorous peer review before being accepted for presentation.
  • Only papers linked to a completed registration will be included in conference proceedings.
  • The submitting author is considered the primary author; ISIT does not verify individual authorship claims.
  • If any concerns regarding authorship arise and are validated, the paper will be withdrawn without reconsideration.
  • Once a paper is removed, it cannot be reintroduced into any ISIT publication.

4. Travel & Accommodation Responsibilities :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.

5. Visa & Invitation Letter Policy :

  • Attendees are responsible for making their own travel and lodging arrangements.
  • ISIT does not provide logistical assistance for travel or accommodation.
  • The organization bears no responsibility for expenses incurred due to conference modifications or rescheduling.
  • ISIT does not engage directly with consulates or embassies on behalf of attendees.
  • Participants must handle their own visa applications and processes.
  • Important Information Regarding Invitation Letters:
    • The invitation letter is provided solely for conference attendance and does not serve as a document for immigration, employment, or residency purposes.
    • The letter assists in visa applications but does not guarantee visa approval.
    • ISIT holds no responsibility for visa denials or processing delays, and all related costs are borne by the applicant.
    • Any alterations or unauthorized use of the invitation letter will result in its invalidation and possible cancellation of conference participation.
    • Legal action may be pursued if the document is misused.
    • By accepting the invitation letter, attendees agree to comply with international travel regulations and ethical participation standards.

6. Registration Transfers :

  • Registrations may be transferred to another individual from the same institution if the original participant cannot attend.
  • Transfer requests must be made via email to info@isit.org.in with necessary details and supporting documents.
  • Transfers must be requested at least 14 days before the event; otherwise, they will not be accommodated.
  • Transferred registrations are not eligible for refunds.

7. General Considerations :

  • Any modifications or cancellations must be communicated in writing to info@isit.org.in.
  • Registration confirms acknowledgment and acceptance of these policies.
  • ISIT does not initiate automatic transactions; all payments are voluntarily completed by registrants.
  • Once registered, participants must submit a conference registration form within three days for confirmation.
  • Travel plans should only be finalized after receiving the official conference itinerary, which will be shared 15 days before the event.
Payments encrypted & processed securely. Refundable up to 14 days before the event.

What you'll hear about

Session tracks covered across the event.
View all 11 tracks →
This track focuses on the latest advancements in cancer treatment modalities, including chemotherapy, radiotherapy, and surgical interventions. Participants will explore novel approaches and their implications for patient outcomes.
This session emphasizes the importance of translating basic cancer research into clinical applications. Discussions will highlight successful case studies and the challenges faced in implementing innovative therapies.
This track will delve into the role of precision medicine in tailoring cancer treatment to individual patient profiles. Emphasis will be placed on genomic profiling and its impact on treatment efficacy.
This session will explore the evolving landscape of immunotherapy in cancer treatment, including checkpoint inhibitors and CAR T-cell therapy. Participants will discuss the mechanisms of action and patient selection criteria.
This track will investigate the molecular and cellular mechanisms underlying tumor biology and the role of the tumor microenvironment. Insights into how these factors influence cancer progression and treatment response will be discussed.
This session will address the intersection of health policy and cancer care, focusing on access to treatment and the implications of policy changes. Participants will evaluate the impact of legislation on cancer research funding and patient care.
This track will highlight cutting-edge technologies that are transforming oncology research and treatment, such as artificial intelligence and machine learning. Discussions will focus on their applications in diagnostics and personalized treatment plans.
This session will explore the importance of palliative care in enhancing the quality of life for cancer patients. Topics will include symptom management, psychosocial support, and the integration of palliative care into oncology practice.
This track will examine the design and implementation of clinical trials in oncology research. Participants will discuss innovative methodologies and the ethical considerations involved in conducting cancer research.
This session will focus on strategies for cancer prevention and the importance of early detection in improving patient outcomes. Topics will include screening programs, risk assessment, and public health initiatives.
This track will provide a platform for discussing global challenges and advancements in oncology research and care. Participants will share insights on disparities in cancer treatment and the importance of international collaboration.